Shadab A. Rahman

Shadab A. Rahman

Auto-generated profile, based on publicly available information

Shadab A. Rahman

Mary Horrigan Connors Center for Women's Health Research, Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA; Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA, USA; Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in SLEEP
Verified
Journal Article
Closed access
SRShadab A. Rahman
Shadab A. Rahman
EFErin E. Flynn-Evans
Erin E. Flynn-Evans
DADaniel Aeschbach
Daniel Aeschbach
GBGeorge C. Brainard
George C. Brainard
CCCharles A. Czeisler
Charles A. Czeisler
SLSteven W. Lockley
Steven W. Lockley
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

15 August 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
SRShadab A Rahman
Shadab A Rahman
LGLeilah K Grant
Leilah K Grant
JGJoshua J Gooley
Joshua J Gooley
Shantha RajaratnamShantha Rajaratnam
Shantha Rajaratnam
CCCharles A Czeisler
Charles A Czeisler
SLSteven W Lockley
Steven W Lockley
Context: Studies suggest that female reproductive hormones are under circadian regulation, although methodological differences have led to inconsistent findings. Objective: To determine whether circulating levels of reproductive hormones exhibit circadian rhythms. Design: Blood samples were collected across ∼90 consecutive hours, including 2 baseline days under a standard sleep-wake schedule and ∼50 hours of extended wake under constant routine (CR) conditions. Setting: Intensive Physiological Monitoring Unit, Brigham and Women’s Hospital. Participants: Seventeen healthy premenopausal women (22.8 ± 2.6 years; nine follicular; eight luteal). Interventions: Fifty-hour CR. Main Outcome Measures: Plasma estradiol (E2), progesterone (P4), LH, FSH, SHBG, melatonin, and core body temperature. Results: All hormones exhibited significant 24-hour rhythms under both standard sleep-wake and CR conditions during the follicular phase (P < 0.05). In contrast, only FSH and SHBG were significantly rhythmic during the luteal phase. Rhythm acrophases and amplitudes were similar between standard sleep-wake and CR conditions. The acrophase occurred in the morning for P4; in the afternoon for FSH, LH, and SHBG; and during the night for E2. Conclusions: Our results confirm previous reports of ∼24-hour rhythms in many female reproductive hormones in humans under ambulatory conditions but demonstrate that these hormones are under endogenous circadian regulation, defined as persisting in the absence of external time cues. These results may have important implications for the effects of circadian disruption on reproductive function.

1 August 2017 in Physiology & Behavior
Verified
Journal Article
Closed access
SRShadab A. Rahman
Shadab A. Rahman
MHMelissa A. St. Hilaire
Melissa A. St. Hilaire
SLSteven W. Lockley
Steven W. Lockley

14 February 2021 in SLEEP
Verified
Journal Article
Open access
PDF file
Jeanne Frances DuffyJeanne Frances Duffy
Jeanne Frances Duffy
SASabra M Abbott
Sabra M Abbott
HBHelen J Burgess
Helen J Burgess
SCStephanie J Crowley
Stephanie J Crowley
JEJonathan S Emens
Jonathan S Emens
EKElizabeth Klerman
Elizabeth Klerman
This White Paper presents the results from a workshop cosponsored by the Sleep Research Society (SRS) and the Society for Research on Biological Rhythms (SRBR) whose goals were to bring together sleep clinicians and sleep and circadian rhythm researchers to identify existing gaps in diagnosis and treatment and areas of high-priority research in circadian rhythm sleep–wake disorders (CRSWD). CRSWD are a distinct class of sleep disorders caused by alterations of the circadian time-keeping system, its entrainment mechanisms, or a misalignment of the endogenous circadian rhythm and the external environment. In these disorders, the timing of the primary sleep episode is either earlier or later than desired, irregular from day-to-day, and/or sleep occurs at the wrong circadian time. While there are incomplete and insufficient prevalence data, CRSWD likely affect at least 800,000 and perhaps as many as 3 million individuals in the United States, and if Shift Work Disorder and Jet Lag are included, then many millions more are impacted. The SRS Advocacy Taskforce has identified CRSWD as a class of sleep disorders for which additional high-quality research could have a significant impact to improve patient care. Participants were selected for their expertise and were assigned to one of three working groups: Phase Disorders, Entrainment Disorders, and Other. Each working group presented a summary of the current state of the science for their specific CRSWD area, followed by discussion from all participants. The outcome of those presentations and discussions are presented here.

1 July 2015 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
SRShadab A. Rahman
Shadab A. Rahman
OCOscar Castanon-Cervantes
Oscar Castanon-Cervantes
FSFrank A.J.L. Scheer
Frank A.J.L. Scheer
SSSteven A Shea
Steven A Shea
CCCharles A. Czeisler
Charles A. Czeisler
SLSteven W. Lockley
Steven W. Lockley
Various aspects of immune response exhibit 24-h variations suggesting that infection susceptibility and treatment efficacy may vary by time of day. Whether these 24-h variations are endogenous or evoked by changes in environmental or behavioral conditions is not known. We assessed the endogenous circadian control and environmental and behavioral influences on ex-vivo lipopolysaccharide stimulation of whole blood in thirteen healthy participants under 48h of baseline conditions with standard sleep-wake schedules and 40-50h of constant environmental and behavioral (constant routine; CR) conditions. Significant 24-h rhythms were observed under baseline conditions in Monocyte Chemotactic Protein, Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin 8 but not Tumor Necrosis Factor alpha whereas significant 24-h rhythms were observed in all four immune factors under CR conditions. The rhythm amplitudes, expressed as a percentage of mean, were comparable between immune factors and across conditions. In contrast, the acrophase time (time of the fitted peak) was different between immune factors, and included daytime and nighttime peaks and changes across behavioral conditions. These results suggest that the endogenous circadian system underpins the temporal organization of immune responses in humans with additional effects of external environmental and behavioral cycles. These findings have implications for understanding the adverse effects of recurrent circadian disruption and sleep curtailment on immune function.

12 December 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MHMelissa St Hilaire
Melissa St Hilaire
MÁMaría L. Ámundadóttir
María L. Ámundadóttir
SRShadab A. Rahman
Shadab A. Rahman
SRShantha M. W. Rajaratnam
Shantha M. W. Rajaratnam
MRMelanie Rüger
Melanie Rüger
SLSteven W. Lockley
Steven W. Lockley
Human circadian, neuroendocrine, and neurobehavioral responses to light are mediated primarily by melanopsin-containing intrinsically-photosensitive retinal ganglion cells (ipRGCs) but they also receive input from visual photoreceptors. Relative photoreceptor contributions are irradiance- and duration-dependent but results for long-duration light exposures are limited. We constructed irradiance-response curves and action spectra for melatonin suppression and circadian resetting responses in participants exposed to 6.5-h monochromatic 420, 460, 480, 507, 555, or 620 nm light exposures initiated near the onset of nocturnal melatonin secretion. Melatonin suppression and phase resetting action spectra were best fit by a single-opsin template with lambda max at 481 and 483 nm, respectively. Linear combinations of melanopsin (ipRGC), short-wavelength (S) cone, and combined long- and medium-wavelength (L+M) cone functions were also fit and compared. For melatonin suppression, lambda max was 441 nm in the first quarter of the 6.5-h exposure with a second peak at 550 nm, suggesting strong initial S and L+M cone contribution. This contribution decayed over time; lambda max was 485 nm in the final quarter of light exposure, consistent with a predominant melanopsin contribution. Similarly, for circadian resetting, lambda max ranged from 445 nm (all three functions) to 487 nm (L+M-cone and melanopsin functions only), suggesting significant S-cone contribution, consistent with recent model findings that the first few minutes of a light exposure drive the majority of the phase resetting response. These findings suggest a possible initial strong cone contribution in driving melatonin suppression and phase resetting, followed by a dominant melanopsin contribution over longer duration light exposures.